Evidence map›Paper›PMID 42592005›Full record

ReviewJournal of cell communication and signaling2026

Broadening horizons: Pathogenesis and therapeutics of renal ciliopathies.

Qiaowei Zhang, Shuwen Xue, Zhi Gao, Panlai Shi, Li Wang, Qi Feng, Xiangdong Kong, Xiaofan Zhu

Abstract readReview
In one paragraph

Review in Journal of cell communication and signaling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qiaowei ZhangDepartment of Obstetrics and Gynecology Genetics and Prenatal Diagnosis Center The First Affiliated Hospital of Zhengzhou University Zhengzhou China.
Shuwen XueDepartment of Obstetrics and Gynecology Genetics and Prenatal Diagnosis Center The First Affiliated Hospital of Zhengzhou University Zhengzhou China.
Zhi GaoDepartment of Obstetrics and Gynecology Genetics and Prenatal Diagnosis Center The First Affiliated Hospital of Zhengzhou University Zhengzhou China.
Panlai ShiDepartment of Obstetrics and Gynecology Genetics and Prenatal Diagnosis Center The First Affiliated Hospital of Zhengzhou University Zhengzhou China.ORCID https://orcid.org/0000-0001-5826-1340
Li WangDepartment of Obstetrics and Gynecology Genetics and Prenatal Diagnosis Center The First Affiliated Hospital of Zhengzhou University Zhengzhou China.
Qi FengDepartment of Nephrology The First Affiliated Hospital of Zhengzhou University Zhengzhou China.ORCID https://orcid.org/0000-0001-8724-5710
Xiangdong KongDepartment of Obstetrics and Gynecology Genetics and Prenatal Diagnosis Center The First Affiliated Hospital of Zhengzhou University Zhengzhou China.ORCID https://orcid.org/0000-0003-4322-914X
Xiaofan ZhuDepartment of Obstetrics and Gynecology Genetics and Prenatal Diagnosis Center The First Affiliated Hospital of Zhengzhou University Zhengzhou China.ORCID https://orcid.org/0000-0002-7303-1700

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal ciliopathies encompass a spectrum of genetic disorders arising from structural or functional impairments of primary cilia, specialized organelles critical for mechanosensation and signal transduction within renal epithelial cells. These disorders are characterized by cystogenesis, driven by dysregulated ciliary signaling, leading to uncontrolled epithelial proliferation, aberrant growth, and loss of cellular polarity. The clinical trajectory evolves from initial cyst formation to advanced tubulointerstitial fibrosis and progressive renal failure. This progression is governed by pathogenic variants in genes encoding ciliary proteins. While advancements in genetic testing have established prenatal diagnosis as a pivotal tool for early identification, definitive diagnosis and therapeutic intervention remain challenging. These difficulties stem from several factors: incomplete understanding of the molecular mechanisms underlying cyst formation and fibrosis; limitations in prenatal diagnostic accuracy owing to phenotypic overlap and incomplete penetrance; and the marked genetic heterogeneity and diverse clinical trajectories of renal ciliopathies. Existing studies have primarily focused on unidirectional modulation of individual pathways, whereas the systematic integration of signaling network cascades remains largely unaddressed. This review systematically elucidates the molecular mechanisms and aberrant signaling pathways in renal ciliopathies, links genetic heterogeneity to clinical phenotypes, and lays a theoretical basis for prenatal diagnosis and novel therapies.

Indexed as

molecular mechanismsprenatal diagnosisprimary ciliarenal ciliopathiessignaling pathways

Identifiers

PMID42592005
PMCPMC13463754

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.